Australia's most trusted
source of pharma news
Posted 2 July 2024 AM
Less than two months after installing a new CEO another five new faces have joined the peak body for the Victorian Healthtech industry, BioMelbourne Network, with a string of Board appointments.
The organisation's Chair and pharma industry veteran who spent more than 30 years at GSK, David Herd, said the newcomers fill the Board with highly experienced ecosystem leaders who will provide strategic guidance as the Association actively fosters and grows the local innovative and globally competitive sector.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.